Banque Cantonale Vaudoise Ac Immune Sa Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Ac Immune Sa stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 18,562 shares of ACIU stock, worth $65,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,562

Previous 25,418 26.97%

Holding current value

$65,895

Previous $101,000 30.69%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$2.99 - $4.2 $20,499 - $28,795	-6,856 Reduced 26.97%	18,562 $70,000
Q2 2024 Jul 31, 2024	SELL	$2.29 - $4.87 $65,759 - $139,846	-28,716 Reduced 53.05%	25,418 $101,000
Q1 2024 Apr 10, 2024	SELL	$2.66 - $4.87 $1,896 - $3,472	-713 Reduced 1.3%	54,134 $160,000
Q4 2023 Feb 07, 2024	SELL	$2.46 - $5.0 $63,600 - $129,270	-25,854 Reduced 32.04%	54,847 $274,000
Q2 2023 Aug 09, 2023	BUY	$1.85 - $3.4 $27,561 - $50,653	14,898 Added 22.64%	80,701 $239,000
Q1 2023 Apr 20, 2023	BUY	$2.13 - $2.49 $49,660 - $58,054	23,315 Added 54.87%	65,803 $154,000
Q4 2022 Feb 10, 2023	BUY	$1.72 - $3.12 $35,143 - $63,747	20,432 Added 92.64%	42,488 $86,000
Q3 2022 Oct 17, 2022	SELL	$2.4 - $3.64 $554 - $840	-231 Reduced 1.04%	22,056 $69,000
Q2 2022 Aug 02, 2022	BUY	$2.35 - $4.47 $1,574 - $2,994	670 Added 3.1%	22,287 $80,000
Q1 2022 May 09, 2022	SELL	$3.5 - $5.16 $102,914 - $151,724	-29,404 Reduced 57.63%	21,617 $86,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $4,820 - $7,544	-998 Reduced 1.92%	51,021 $253,000
Q3 2021 Oct 29, 2021	SELL	$6.2 - $8.34 $121,712 - $163,722	-19,631 Reduced 27.4%	52,019 $349,000
Q2 2021 Aug 11, 2021	BUY	$6.04 - $8.37 $1,328 - $1,841	220 Added 0.31%	71,650 $568,000
Q1 2021 May 11, 2021	BUY	$5.32 - $8.96 $69,931 - $117,779	13,145 Added 22.55%	71,430 $544,000
Q4 2020 Feb 05, 2021	BUY	$4.47 - $5.58 $11,246 - $14,039	2,516 Added 4.51%	58,285 $303,000
Q3 2020 Oct 30, 2020	BUY	$4.78 - $9.06 $212,494 - $402,762	44,455 Added 392.92%	55,769 $272,000
Q2 2020 Jul 22, 2020	SELL	$6.57 - $8.3 $2,384 - $3,012	-363 Reduced 3.11%	11,314 $76,000
Q1 2020 May 14, 2020	SELL	$4.24 - $9.89 $1,212 - $2,828	-286 Reduced 2.39%	11,677 $81,000
Q4 2019 Feb 10, 2020	BUY	$4.56 - $8.78 $54,551 - $105,035	11,963 New	11,963 $102,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Ac Immune Sa Transaction History